The human MICA (MHC I-related chain A) gene, encoding a ligand for the NKG2D (NKG2-D type II integral membrane protein) receptor, is highly polymorphic. A group of MICA alleles, named MICA 5.1 (prototype, MICA*008), produce a truncated protein due to a nucleotide insertion in the transmembrane domain. These alleles are very frequent in all of the human populations studied and they have different biological properties, compared with full-length alleles, e.g. recruitment into exosomes, which makes them very potent for down-modulating the NKG2D receptor in effector immune cells. Moreover, MICA*008 is not affected by viral immune evasion mechanisms that target other MICA alleles. In the present study, we demonstrate that MICA*008 acquires a GPI (glycosylphosphatidylinositol) anchor and that this modification is responsible for many of the distinct biological features of the truncated MICA alleles, including recruitment of the protein to exosomes. MICA*008 processing is also unusual as it is observed in the endoplasmic reticulum as a Triton TM X-114 soluble protein, partially undergoing GPI modification while the rest is exocytosed, suggesting a new model for MICA*008 release. This is the first report of a GPI-anchored MICA allele. The finding that this modification occurs in both families of human NKG2D ligands, as well as in the murine system, suggests positive pressure to maintain this biochemical feature.
INTRODUCTION
The interaction of the NKG2D (NKG2-D type II integral membrane protein) receptor with its ligands plays an important role in immune recognition of cancer and infection by cytotoxic lymphocytes of both the innate and adaptive arms of the immune system. This receptor-ligand system has many implications for human health since it can modulate the immune response in cancer patients and the presence of soluble NKG2D-Ls (NKG2D ligands) has been correlated with worse prognosis [1] . A remarkable feature of this system is that a single receptor binds several ligands encoded in two separate gene families related to MHC: the MICA/B (MHC I-related chain A/B) genes [2] and the ULBPs (UL16-binding proteins; also known as RAET) [3] , a multigene family of mostly GPI (glycosylphosphatidylinositol)-anchored proteins. The MICA and MICB genes are highly polymorphic and it has been argued that the appearance of multiple NKG2D-Ls during the evolution of the immune system has been driven by varying selection pressures exerted by pathogens or cancer [4] . A striking polymorphism in MICA consists of a number of repetitions of a trinucleotide in the TM (transmembrane) region, leading to the insertion of four to nine alanine residues. A second group of alleles, known as MICA*A5.1 (MICA*008, MICA*023, MICA*028 and MICA*054), has a single nucleotide insertion in the exon encoding the TM region and, consequently, a frame shift leading to the expression of a truncated protein [5] . Since no clear TM region was noted in these alleles, it was first thought that these truncated MICA proteins could be secreted molecules [6] , but MICA*008 is observed at the cell surface of tumour cell lines [7] [8] [9] and in transfectants [10, 11] . Interestingly, MICA*A5.1 are the most frequently expressed alleles of MICA in diverse populations worldwide, with an allele frequency ranging from 21 to 47% [7, [12] [13] [14] . Although the high occurrence of MICA*A5.1 in all these populations may reflect an advantage for pathogen immune surveillance, genetic studies have also associated expression of this allele with a number of disease pathologies, including Behçet's disease and psoriasis, however, the mechanisms underlying these associations with disease remain unclear [15] .
Several biological differences between full-length and truncated MICA alleles have been described (Table 1) . For example, although surface expression of many MICA molecules is blocked in cells infected by HCMV (human cytomegalovirus) or KSHV (Kaposi sarcoma-associated herpesvirus), the MICA*008 allele resists down-regulation by these viruses [16] [17] [18] [19] . Cell biology and trafficking properties also differ between full-length and truncated MICA alleles (for review see [20] ), including recruitment of MICA*008 to the apical membrane in polarized
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Since differences between NKG2D-L can markedly affect host immunity, we have studied in detail the biochemical properties of the most commonly expressed allele of MICA, MICA*008, and our analysis demonstrates that MICA*008 is synthesized in the ER (endoplasmic reticulum) as a soluble protein that becomes attached to the membrane via a GPI anchor in a process requiring an unusually long time. We show that the peculiar biology of MICA*008 depends on the presence of the GPI anchor and propose a new model for the complex release of MICA*008. This is the first example of a MICA/B molecule with this type of membrane attachment and poses the question of why both families of NKG2D-Ls, MIC and ULBP, have evolved to contain both TM and GPI-anchored proteins.
EXPERIMENTAL

Cells and reagents
CHO (Chinese-hamster ovary) cells, the GPI-deficient mutant CHO G9-PLAP-0.85 (referred to as CHO-GPI or GPI-neg) [25] (gifts from Dr Victoria L. Stevens, Epidemiology Research Program, American Cancer Society, Atlanta, GA, U.S.A. and Dr Saulis Vainauskas and Dr Anant K. Menon, Department of Biochemistry, Cornell University, New York, NY, U.S.A.) and CHO cells transfected with MICA*019, MICA*008 and the ULBP1-3 molecules have been described previously [11, 26, 27] . CHO and CHO-GPI cells were transfected and selected as described previously [26] .
HeLa and HEK (human embryonic kidney)-293T cells were cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS, L-glutamine and sodium pyruvate.
Antibodies against ULBPs and polyclonal antibodies against MICA were purchased from R&D Systems. Hybridoma eh1C9b against murine CD63 (cluster of differentiation 63 antigen) and hybridomas against murine LAMP1 (lysosomal-associated membrane protein 1) (lgpB) were provided by Jane Turner [MRC (Medical Research Council)-UCL (University College London), London, U.K.]. The 1H10 hybridoma was obtained from Dr Andrew G. Brooks (Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia) [28] . Monoclonal antibody 1H10 against MICA and B94 antibody against CD8 as isotype control were purified from supernatant by chromatography on Protein G-Sepharose. Leupeptin, pepstatin A, BFA (brefeldin A), monensin, Triton TM X-114 and PI-PLC (phosphatidylinositol-specific phospholipase C) were purchased from Sigma-Aldrich.
Western blot
Cells were lysed in buffer containing 50 mM Tris, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 % Nonidet P40 and the protease inhibitors, 1 μg/ml leupeptin and 1 μg/ml pepstatin, for 30 min at 4
• C. Nuclei were eliminated by centrifugation at 13 000 g. Lysates and membrane/soluble fractions were run on SDS/PAGE (10-12 % gels) and transferred on to Immobilon-P (Millipore) membrane. The membrane was blocked using PBS-T (PBS containing 0.1 % Tween 20) and 5 % non-fat dried skimmed milk powder. Detection of MIC was performed by incubation with either biotinylated or unlabelled goat polyclonal anti-MIC antibody (R&D Systems), followed by HRP (horseradish peroxidase)-conjugated streptavidin or the appropriate HRPconjugated secondary antibody. Proteins were visualized using the ECL system (GE Healthcare). In some experiments, samples were treated with endo H (endoglycosidase H) or endo F [endoglycosidase F; also known as N-glycanase and PNGaseF (peptide N-glycosidase F)] (New England Biolabs) according to the manufacturer's instructions.
Triton TM X-114 fractionation
Soluble and membrane-anchored proteins were fractionated by extraction with Triton TM X-114 as described previously [26] and analysed separately by SDS/PAGE after TCA (trichloroacetic acid) precipitation.
Flow cytometry
Cells (10 5 ) were pre-incubated in PBS containing 1 % BSA and 0.1 % sodium azide. Cells were then incubated with mouse monoclonal antibodies and bound antibody was visualized using either phycoerythrin-or FITC-labelled F(ab ) 2 fragments of goat anti-(mouse Ig) (Dako). Samples were analysed using a FACScan II flow cytometer (Becton Dickinson). Dead cells were excluded from all analyses by staining with propidium iodide. For intracellular staining, cells were fixed with 2 % p-formaldehyde for 10 min at 25
• C and permeabilized with 1 % saponin in PBS for 10 min at 25
• C. Staining was carried out as above. For PI-PLC treatment, 10 5 cells were washed and resuspended in 25 mM Tris, pH 8, 150 mM NaCl and incubated for 30 min to 2 h with the enzyme.
Surface biotinylation and immunoprecipitation
Cells ( 2×10 7 ) were washed four times with ice-cold PBSCaMg (PBS containing CaCl 2 and MgCl 2 ) and surface labelled by incubation with 0.25 mg/ml sulfo-NHS-LC-biotin [sulfosuccinimidyl-6-(biotinamido)hexanoate] in PBS-CaMg for 30 min at 4
• C. After washing with PBS containing 0.5 % BSA and three more washes with PBS-CaMg, cells were recovered from the dish and lysed by incubation in buffer containing 50 mM Hepes, pH 7.6, 5 mM CaCl 2 , 5 mM iodoacetamide, 1 % digitonin and the protease inhibitors leupeptin and pepstatin for 30 min at 4
• C. Nuclei were eliminated by centrifugation at 13 000 g and, after preclearing with Pansorbin (Calbiochem), the lysates were divided into two aliquots for immunoprecipitation with either irrelevant antibody (antibody against CD8, B94) or anti-MICA antibody (1H10) coupled with Sepharose beads. Incubation with antibody-coupled beads was carried out for 16 h at 4
• C. After washing with lysis buffer three times, aliquots were kept either undigested or digested with PNGaseF. Proteins were run on SDS/PAGE (10-12 %), transferred to Immobilon-P and processed as for other Western blots (see above).
Exosome fractionation
Exosomes were isolated by differential centrifugation as described previously [11] .
ELISA
Cells were treated for 30 min with either monensin (2.5 μM), BFA (50 μg/ml) or BB-94 (Batimastat) (5 μM), washed with PBS and incubated for a further 2 h in medium supplemented with the indicated inhibitors. The release of soluble MICA was measured using a sandwich ELISA [24] .
Pulse-chase experiments
CHO cells (4×10 7 ) were harvested and starved for 30 min in 2 ml of methionine/cysteine-free medium. Cells were then incubated in 2 ml of methionine/cysteine-free medium containing 1 mCi of [
35 S]methionine for 10 min and chased for the indicated times. Cell lysates were prepared in 1 % Nonidet P40 or Triton TM X-114 lysis buffer. After preclearing the lysate with Pansorbin (Calbiochem), MICA proteins were recovered by immunoprecipitation using a mixture of the monoclonal antibodies against 6D4 (Santa Cruz) and AMO1 (Immatics Biotechnologies). Immunoprecipitated proteins were recovered using Protein G beads (GE Heathcare), washed three times in lysis buffer and digested with endo H (NEB), following the manufacturer's instructions. Proteins were resolved in SDS/PAGE (10 % gel). 
RESULTS AND DISCUSSION
Intracellular MICA*008 exists as a soluble and a membrane-bound protein MICA*008 and MICA*019 are almost identical in the extracellular domain, but very different in the C-terminal region [11] . Western blot analysis of deglycosylated MICA shows that MICA*008 migrated as two bands with apparent Mws (molecular masses) of ∼34 kDa and ∼37 kDa, whereas MICA*019 protein always migrated as a single band ( Figure 1A ). Fully glycosylated MICA*008 migrated as a smear, indicating variations in carbohydrate composition of MICA*008 expressed in the different cell lines. However, after deglycosylation using PNGaseF, the same size (34 kDa and 37 kDa) bands were seen in all the cases, although the relative proportions of these two species did vary somewhat between cell lines. Importantly, MICA*008 endogenously expressed by HEK-293T cells also migrated as two bands [8] , confirming that this pattern was not an artefact of overexpression.
To explore the identity of the two MICA*008 bands, fractionation experiments in the presence of Triton TM X-114 were performed. The physical properties of this detergent allow separation of soluble and membrane-bound proteins, including organelle membranes. Cell lysates prepared in Triton TM X-114 at 4
• C, when transferred to temperatures of 30-37 • C, fractionate into two phases: a detergent-rich phase containing membrane proteins and an aqueous phase containing soluble hydrophilic proteins [29] . In order to distinguish between plasma membrane and internal cell membranes, CHO cells expressing either MICA*008 or MICA*019 were surface biotinylated before lysis and fractionation in Triton TM X-114. Surface molecules were recovered with streptavidin-Sepharose beads. Proteins were digested with either endo H or PNGaseF and, subsequently, MICA was analysed by Western blotting in both total lysate and cell-surface phases ( Figure 1B) . The upper band of MICA*008 fractionated mainly in the aqueous (soluble) phase, whereas the lower band was found mainly in the detergent phase and is thus membrane attached. Consistent with these data, PNGaseFdigested (deglycosylated) biotinylated MICA*008 (thus cell surface expressed) had an apparent Mw of ∼34 kDa, whereas the ∼37 kDa MICA*008 band was not detected with streptavidin, indicating that this form of the protein was intracellular. MICA*019 fractionated mainly in the detergent phase (membrane bound) and was labelled with biotin, as expected for a TM protein.
Fractionation efficiency was controlled by analysing the presence of two integral membrane proteins, LAMP1 and CD63, that were only found in the detergent phase ( Figure 1C ). Thus, whereas MICA*019 is always membrane bound, MICA*008 exists in the cell in two forms; a soluble intracellular species of ∼37 kDa and a ∼34 kDa cell-surface membrane protein. The presence of these two bands strongly suggests that the MICA*008 protein undergoes post-translational modifications that lead to differences in migration on SDS/PAGE.
MICA*008 molecules are attached to the membrane by a GPI
The fact that the membrane-bound form of MICA*008 migrates faster in SDS/PAGE than the soluble one initially suggested cleavage of the protein. However, another possibility is the addition of a charged modification that changes its migration rate. One of the modifications acquired by many NKG2D-Ls is the replacement of a short TM region with a GPI moiety [3] . Thus we tested whether MICA*008 could be modified by GPI. Treatment with PI-PLC, an enzyme that specifically cleaves the GPI anchor, showed that MICA*008 can be expressed at the cell surface as a GPI-linked protein (Figures 2A and  2B ). The specificity of the PI-PLC digestion was demonstrated in control experiments, using CHO cells expressing either MICA*019 protein or GPI-anchored ULBPs. Similar data were obtained after PI-PLC treatment of HEK-293T cells endogenously expressing MICA*008 (and homozygous for this allele) [7, 8] ( Figure 2C ). Although surface expression was lower, these experiments also showed that, on average, almost 60 % was susceptible to PI-PLC digestion (44 % of MICA*008 remained at the cell surface), whereas no MICA*019 was removed by PI-PLC (100 % remained after digestion). The persistence of a proportion of a GPI-anchored protein on the cell surface after PI-PLC digestion is not unusual. For example, ULBP1 was digested more efficiently than ULBP2 and ULBP3 [3] (Figure 2 ). This often occurs because of fatty acid modifications of the inositol moiety that block nucleophilic attack by the phospholipase [30] . Interestingly, it has been shown that some GPI-linked proteins, such as decay-accelerating factor, can exhibit differential inositol acylation and that this structural variation is regulated in a cellspecific fashion, but can also be protein dependent [31] . Western blot analysis of cell-free supernatants after PI-PLC digestion confirmed the release of MICA*008 from the PI-PLC treated cells (Figure 2A, inset) .
To complement the PI-PLC digestion experiments, surface expression of MICA*019 and MICA*008 was also analysed by flow cytometry of transiently transfected wt (wild-type) CHO cells and the GPI-deficient cell line G9-PLAP-0.85 (CHO-GPI) [25] (Supplementary Figure  S1A at http://www.biochemj.org/bj/454/bj4540295add.htm). MICA*008 was expressed at the plasma membrane of GPI cells at much lower levels than those seen in wt cells, suggesting that the machinery for the addition of GPI anchors is necessary for efficient delivery of MICA*008 to the cell surface. Furthermore, Western blot analysis showed that the lower band of MICA*008 (cell-surface membrane-bound) was absent in GPI cells indicating that the 34 kDa band corresponds to a GPI-linked molecule (Supplementary Figure S1B) .
To analyse the role of the C-terminal region of MICA*008 in directing the acquisition of a GPI modification, a chimaeric construct containing the extracellular region of MICA*019 and the C-terminus of MICA*008 was studied in PI-PLC digestion experiments (Supplementary Figures S2A and S2B at http://www.biochemj.org/bj/454/bj4540295add.htm). These data demonstrate that the chimaera acquired susceptibility to digestion with PI-PLC. Furthermore, fusion of GFP to the C-terminal region of MICA*008 was sufficient to allow acquisition of a GPI modification by the reporter protein ( Supplementary Figures S2C  and S2D ).
In summary, these experiments show that the majority of surface MICA*008 is attached to the plasma membrane via a GPI anchor and that the C-terminal region dictates the modification. Proteins were digested with PNGaseF and run on SDS/PAGE. Left-hand panel, surface biotinylated protein, visualized using HRP-conjugated streptavidin. Right-hand panel, total lysate, visualized using polyclonal anti-MICA antibody. The bands above 50 kDa are non-specific, as they also appear in the isotype control IP (immunoprecipitate). (B) Flow cytometry of the same stable transfectants. As indicated, surface and surface plus intracellular (permeabilized) staining were performed. (C) Exosome fractionation of CHO-MICA*019, CHO-MICA*008 and GPI-MICA*008 cells. The total lysate (Lys), the soluble fraction at 100 000 g (SN) and exosomes (Exo; 100 000 g pellet) were analysed by Western blot for the expression of MICA. CD63 was analysed as control for the exosome fractionation. Experiments were performed at least three times and a representative experiment is depicted in each panel.
The GPI anchor controls MICA*008 recruitment to DRMs and exosomes and non-GPI MICA*008 accumulates inside the cell
We have shown previously that MICA*008 is found in exosomes, both in transfectant and in endogenous systems, and that the Cterminal region of MICA*008 governs its recruitment to DRMs and exosomes [11] . To test whether the GPI anchor confers these properties, we compared the biochemistry of MICA*008 stably expressed in normal CHO cells or the GPI-deficient cell line, GPI. First, we observed that, in the absence of GPI machinery, stable transfectants did not maintain surface expression of MICA*008: stably transfected cells (CHO-MICA*019, CHO-MICA*008 and GPI-MICA*008) were surface biotinylated and, after MICA immunoprecipitation, analysed by Western blot for both surface and total MICA ( Figure 3A) . In these blots, the presence of two bands for MICA*008 was confirmed in the total lysate of the wt cell line, whereas there was only one in the surface and in the GPI transfectants. These experiments show that, although in stable transfectants MICA*008 was minimally expressed at the cell surface of GPI cells, it was still present within the cell. This conclusion was supported by flow cytometry staining for surface and intracellular MICA ( Figure 3B) .
Analysis of MICA*008 in the supernatant of transfected wt and CHO-GPI cells demonstrated that, although MICA*008 released from wt CHO cells was present in exosomes as reported previously [11] , the protein released by the GPI cell line was not found in these vesicles, but instead was found to be soluble ( Figure 3C ). Exosome fractions had similar levels of CD63, indicating that exosomes were correctly purified in the three cell lines. Similarly, analysis of the recruitment of MICA*008 to DRMs (Supplementary Figures S3A and S3B at http://www.biochemj.org/bj/454/bj4540295add.htm) showed that, although MICA*008 was predominantly found in DRMs in wt CHO cells and tumour cell lines endogenously expressing this allele, no MICA*008 was found in DRMs isolated from the CHO-GPI cells.
These experiments confirm the importance of the GPI anchor for stable expression at the plasma membrane and in the recruitment of MICA*008 to DRMs and exosomes.
A proportion of MICA*008 is secreted to the extracellular medium devoid of the GPI modification
The presence of soluble MICA*008 in the 100 000 g supernatant of the MICA*008 expressing CHO and CHO-GPI cells was intriguing ( Figure 3C and [11] ) and prompted investigation on the origin of these soluble molecules. The possible mechanisms of release to the extracellular medium were studied by ELISA analysis of the supernatants of cells treated with inhibitors of various processes ( Figure 4A ), including metalloprotease cleavage, inhibited by BB-94, and known to be involved in the shedding of MICA*019 [23] . The release of soluble MICA*008 was affected by inhibitors of protein exocytosis, such as monensin and BFA, but not by metalloprotease inhibition. Surface expression was not affected by treatment with any of these inhibitors (Supplementary Figure  S4 at http://www.biochemj.org/bj/454/bj4540295add.htm). Interestingly, considerable amounts of soluble protein were present in the supernatants of the GPI cells despite almost no surface expression of MICA*008 (as shown in Figures 3A and 3B ). On inspection of Western blot analyses of the proteins present in the supernatants after 100 000 g centrifugation (Figure 3C ), the MICA*008 band corresponding to the intracellular soluble species (37 kDa) can be observed in both wt and GPI cells, i.e. independently of the presence of GPI. This confirms that when MICA*008 does not acquire the GPI modification it is released in the supernatant. Overall, these data suggest that the soluble species of MICA*008 (non-GPI anchored) was released by exocytosis.
To better understand the synthesis and processing of MICA*008, its maturation rate was analysed in pulse-chase experiments, in which the ER exit time of a pool of 35 Slabelled proteins can be examined by assessing its ability to acquire resistance to endo H digestion. In addition, in order to characterize the appearance of the membrane-bound form of MICA*008, the experiment also includes digestion with PNGaseF. MICA*019 was used as the control. CHO cells stably expressing either MICA*019 or MICA*008 were labelled with [
35 S]methionine/cysteine for 10 min and chased for the indicated times ( Figure 4B , and Supplementary Figure  S5A at http://www.biochemj.org/bj/454/bj4540295add.htm). MICA*019 acquired endo H resistance after 30 min of chase, indicating that this molecule progressed past the ER at a rate similar to classical MHC I molecules. In contrast, MICA*008 required a much longer time of chase before the mature fully glycosylated protein could be clearly observed. The appearance of the mature MICA*008 band, corresponding to the GPIanchored form, required two steps: first, during the initial 30 min after synthesis of MICA*008, the changes in size of Figure 5 Model for MICA*008 trafficking MICA*008 was found to be a Triton TM X-114-soluble protein in the ER, acquiring a GPI modification in a very slow process (1). The GPI-anchored protein travels through the secretory pathway to reach the plasma membrane (2) . According to the current model for biogenesis of exosomes, the surface protein would be internalized and recruited to early endosomes (EEs) and to the internal membranes of multivesicular bodies (MVBs) before being released to the extracellular milieu, as part of exosomes (3). On the other hand, a proportion of the ER-soluble protein that was not modified by a GPI (4) would travel to the cell surface, presumably through the secretory pathway (broken arrow), and then released by exocytosis to the extracellular milieu (5). Other alternative cellular routes are indicated as narrower arrows. ERGIC, ER-Golgi intermediate compartment; LE, late endosome.
the undigested samples indicated carbohydrate modifications, i.e. trimming of the N-glycosylation moieties before exit from the ER (see the differences in size of the undigested bands at approximately 45-55 kDa and compare with the equal migration of these same samples after endo H digestion). Secondly, this process was followed by a slow exit from the ER. The band with an apparent Mw of ∼34 kDa after PNGaseF digestion corresponding to the cell-surface membranebound protein ( Figure 1B ) was first detected after 2 h, but was only clearly visible after long chase times, indicating that the process of membrane attachment is either inefficient or in a minority. The appearance of this band was simultaneous with the detection of the endo H-resistant species of MICA*008. Further analysis of the pulse-chase experiment by Triton TM X-114 fractionation confirmed that the bands observed in the pulsechase experiments correspond to the soluble and membrane forms of the protein described in Figure 1 (B) (Supplementary Figure S5B) . These data show that MICA*008 is synthesized as a soluble protein that subsequently becomes attached to the plasma membrane in a slow process involving post-translational modification with a GPI moiety. Usually, GPI-anchored proteins are integral at the ER membrane and transferred to the GPI anchor by the activity of a multienzymatic complex [32] . Since this process appears to leave much MICA*008 unbound to the membrane, we suggest a hypothesis for MICA*008 trafficking ( Figure 5 ). We propose that after its synthesis in the ER, the protein can follow two alternative pathways: first, to become attached to the GPI moiety, or secondly, to remain soluble and be secreted to the extracellular milieu. It seems that MICA*008 is following a non-standard process for its membrane attachment and, for this reason, the composition of the GPI anchor will be studied as a manner to identify organelles and enzymes involved.
In summary, we demonstrate that the most frequent allele of MICA in the majority of human populations studied, MICA*008, is synthesized as a soluble protein that, after further processing, either attaches to the membrane through a GPI anchor or remains soluble in intracellular compartments to later be released by exocytosis. This is the first evidence of a MICA molecule possessing a GPI anchor, a finding with important implications for our understanding of the biology and disease associations of this molecule. The high frequency of MICA*008 in human populations suggests that the expression of MICA molecules with either TM or GPI anchors represents an evolutionary advantage for immune recognition. It is striking that the other human family of NKG2D-Ls, the ULBPs, also comprises both TMand GPI-anchored proteins, as do murine NKG2D-L [1] . These observations reinforce the idea that there is some advantage associated with the expression of NKG2D-Ls with different membrane anchors, but the nature of that advantage is not clear. We have proposed that the differences in membrane attachment might be more important for intracellular trafficking than for immune recognition [20] ; however, it has also been reported that replacement of the GPI anchor of ULBP1 with the TM domain of CD45 led to a marked reduction in NK recognition [33] , but the basis of this effect was not identified.
The GPI modification probably explains the differences between the cell biology of MICA*008 and other MICA alleles as well as the different interactions with several viral immune evasion proteins and could also be important in immune surveillance of the gut epithelium where, even in healthy individuals, MICA molecules are expressed [34] . Full-length MICA alleles, sorted to the basolateral membrane [21] , will be in contact with intraepithelial lymphocytes, whereas MICA*008, directed to the apical surface, will be visible to the lumen of the gut. These data, establishing important biochemical differences between alleles of MICA, suggest that a full understanding of the significance for prognosis of the presence of NKG2D-Ls in diseases such as cancer and autoimmunity will need to consider whether the molecule being analysed is a TM or a GPI-anchored NKG2D-L, in exosomes (multimeric) or soluble (monomeric).
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CONSTRUCT OF CHIMAERIC PROTEINS AND TRANSFECTION
The chimaeric molecule containing the extracellular portion of MICA*019 and the C-terminus of MICA*008 has been described previously [1] .
The chimaeric molecule containing EGFP attached to the C-terminus of MICA*008 was prepared by ligation into PCDNA3.1 of three fragments: first, leader sequence of CD5, obtained by HindIII/KpnI digestion from a plasmid described previously [2] ; secondly, full-length EGFP, obtained by PCR amplification, using as template pEGFP-C1 and the primer pair 5 -GGGGTACCCATGGTGAGCAAGGGCG-3 and 5 -CCCAGCTGCTTGTACAGCTCGTCCATG-3 , followed by KpnI and PvuII digestion; and thirdly, MICA*008 C-terminal region, obtained by digestion with PvuII and EcoRI, from a plasmid containing this molecule (as described previously [1] ). DNA was extracted from bacteria colonies transformed with the ligation product and the construct was sequenced by the Core Facility of the Technology Park in Madrid, Spain. Sequence analysis was carried out with tools from the European Bioinformatics Institute (http://www.ebi.ac.uk); sequence alignments were prepared with the ClustalW program [3] . Restriction enzymes were purchased from NEB.
Transfection of the construct into CHO cells was carried out as described previously [4] . To generate a stable transfectant cell line, GFP-positive cells were selected by flow cytometry using a Coulter Epics Altra (Beckman Coulter) at the Flow Cytometry Facility of the CNB-CSIC.
CELL-SURFACE DETECTION OF GFP-MICA*008 C-TERMINUS BY FLOW CYTOMETRY
Cells (10 5 ) were pre-incubated in PBS containing 1 % BSA and 0.1 % sodium azide (Sigma-Aldrich). Cells were incubated for 1 h on ice with a mouse monoclonal antibody against GFP (Roche). After being washed in PBS, cells were incubated with phycoerythrin-labelled F(ab ) 2 fragments of goat antibody directed against mouse Ig (Dako) for 30 min on ice. Cells were analysed for expression of GFP with a FACScan (Becton Dickinson).
DRM FRACTIONATIONS
Detergent-resistant and detergent-soluble membrane fractions were prepared and analysed as described previously [1] . 
